Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressant Therapy for Functional Dyspepsia
NCT00248651Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2006
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of amitriptyline, Escitalopram oxalate oral solution in functional dyspepsia (FD), sponsored by Mayo Clinic. Started Oct 2006; status: completed.
02
Drugs
amitriptylineEscitalopram oxalate oral solution
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT00248651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248651.